Translational Research for Neural Implants
Webinar

Translational Research for Neural Implants 

John Donoghue and Vasiliki (Vasso) Giagka will discuss the latest bioengineering advances for implantable devices that treat neurological disorders.

Share

This webinar will be hosted live and available on-demand

Monday, May 8, 2023 
11:00 AM Eastern Time 

Implantable neurotechnologies already treat various disorders, including epilepsy, Parkinson’s disease, depression, and pain. As researchers develop new materials and technologies, the therapeutic potential of neural implants for other diseases and conditions grows. 

In this webinar brought to you by The Scientist, John Donoghue and Vasiliki (Vasso) Giagka will present their latest findings on applying clinical and technical developments to create new implantable devices for treating neurological disorders. 

Topics to be covered 

  • Successes, challenges, and opportunities for brain computer interfaces (BCIs)
    • Accomplishments in human implantable BCIs over the last decades
    • Current capabilities for movement and communication
    • Challenges for clinically useful BCIs as medical devices
  • Miniaturized and selective active neural interfaces
    • Active neural implants for bioelectronic medicine
    • Miniaturization of active neural implants
    • Multimodal neural interfaces
John

John Donoghue, PhD
Professor
Carney Brain Institute
Department of Neuroscience and School of Engineering
Brown University

Vasiliki

Vasiliki (Vasso) Giagka, PhD
Assistant Professor
Department of Microelectronics
Delft University of Technology
Principal Investigator
Technologies for Bioelectronics, System Integration, and Interconnection Technologies
Fraunhofer Institute for Reliability and Microintegration IZM


Top Image Credit:

Translational Research for Neural Implants

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies